Page last updated: 2024-10-30

metformin and Hypertension, Portal

metformin has been researched along with Hypertension, Portal in 4 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Hypertension, Portal: Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN.

Research Excerpts

ExcerptRelevanceReference
"Portal hypertension is the main determinant of clinical decompensation in patients with liver cirrhosis."3.01Randomised clinical study: acute effects of metformin versus placebo on portal pressure in patients with cirrhosis and portal hypertension. ( Aagaard, NK; George, J; Grønbaek, H; Jessen, N; Rittig, N; Sandahl, TD; Villadsen, GE, 2021)
"Metformin-treated CCl4-cirrhotic rats had lower PP and hepatic vascular resistance than vehicle-treated rats, without significant changes in MAP or PBF."1.42Metformin reduces hepatic resistance and portal pressure in cirrhotic rats. ( Bosch, J; Erice, E; García-Calderó, H; García-Pagán, JC; Gracia-Sancho, J; Lafoz, E; Sarin, SK; Tripathi, DM, 2015)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Rittig, N2
Aagaard, NK2
Villadsen, GE2
Sandahl, TD2
Jessen, N2
Grønbaek, H2
George, J2
Palaniyappan, N1
Fallowfield, JA1
Tripathi, DM1
Erice, E1
Lafoz, E1
García-Calderó, H1
Sarin, SK1
Bosch, J1
Gracia-Sancho, J1
García-Pagán, JC1

Trials

1 trial available for metformin and Hypertension, Portal

ArticleYear
Randomised clinical study: acute effects of metformin versus placebo on portal pressure in patients with cirrhosis and portal hypertension.
    Alimentary pharmacology & therapeutics, 2021, Volume: 54, Issue:3

    Topics: Humans; Hypertension, Portal; Liver Cirrhosis; Metformin; Portal Pressure

2021

Other Studies

3 other studies available for metformin and Hypertension, Portal

ArticleYear
Editorial: metformin for portal hypertension-old dog, new tricks?
    Alimentary pharmacology & therapeutics, 2021, Volume: 54, Issue:3

    Topics: Humans; Hypertension, Portal; Metformin

2021
Editorial: metformin for portal hypertension-old dog, new tricks? Authors' reply.
    Alimentary pharmacology & therapeutics, 2021, Volume: 54, Issue:3

    Topics: Humans; Hypertension, Portal; Liver Cirrhosis; Metformin

2021
Metformin reduces hepatic resistance and portal pressure in cirrhotic rats.
    American journal of physiology. Gastrointestinal and liver physiology, 2015, Sep-01, Volume: 309, Issue:5

    Topics: Animals; Blood Pressure; Hypertension, Portal; Liver; Liver Cirrhosis; Male; Metformin; Portal Vein;

2015